Riskpilot← Back to searchSign inGet full accessNordic Formulation Technology A/S
A/SActiveCVR 11158390Søholm Park 1Wholesale of chemical products · NACE 4685Est. 198714 employees
Revenue 2025
DKK 11,4M
+90% vs 2024
EBITDA margin
81.9%
+123% vs 2024
Equity ratio
81.0%
Financial strength
Net profit 2025
DKK 7,6M
+99% vs 2024
| Revenue | DKK 11,4M | +90% |
| EBITDA | DKK 9,3M | +123% |
| Net profit | DKK 7,6M | +99% |
| Total assets | DKK 46,5M | +29% |
| Equity | DKK 37,6M | +25% |
| Employees | 14 | — |
Legal name
Nordic Formulation Technology A/S
CVR number
11158390
Legal form
Aktieselskab
NACE code
4685 · Wholesale of chemical products
Founded
31. august 1987
Share capital
DKK 501.000
Employees
14 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse
Company purpose
Selskabets formål er at drive fabrikation og handel
Address
Søholm Park 1
Phone
+4535436611
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.708 | 9.802 | 7.210 | 12.329 | 12.359 | 10.847 | 8.934 | 4.335 | 7.510 | 9.561 | 8.051 | 6.295 | 5.966 | 11.352 |
| Staff expenses | -2.390 | -2.242 | -2.231 | -2.265 | -2.333 | -2.303 | -2.251 | -625 | -2.128 | -2.297 | -2.380 | -1.712 | -1.803 | -2.058 |
| EBITDA | 17.319 | 7.560 | 4.979 | 10.064 | 10.026 | 8.529 | 6.682 | 3.710 | 5.383 | 7.244 | 5.671 | 4.582 | 4.163 | 9.293 |
| Depreciation & amort. | -100 | -75 | -122 | -116 | -72 | -73 | -109 | -36 | -108 | -78 | -63 | -63 | -48 | -45 |
| EBIT | 17.219 | 7.485 | 4.857 | 9.948 | 9.954 | 8.455 | 6.573 | 3.674 | 5.275 | 7.166 | 5.607 | 4.519 | 4.115 | 9.248 |
| Net financials | 578 | 30 | 11 | 2 | 0 | 7 | -0 | -0 | -10 | -65 | -88 | 133 | 806 | 518 |
| Profit before tax | 17.797 | 7.515 | 4.868 | 9.950 | 9.954 | 8.462 | 6.573 | 3.673 | 5.265 | 7.102 | 5.520 | 4.652 | 4.920 | 9.767 |
| Tax | 4.279 | 2.054 | 1.186 | 2.340 | 2.192 | 1.864 | 1.448 | 810 | 1.160 | 1.564 | 1.217 | 1.202 | 1.086 | 2.151 |
| Net profit | 13.518 | 5.461 | 3.682 | 7.610 | 7.762 | 6.598 | 5.125 | 2.863 | 4.104 | 5.537 | 4.302 | 3.450 | 3.834 | 7.616 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 30.321 | 17.115 | 16.760 | 20.185 | 22.181 | 23.353 | 21.824 | 17.515 | 21.242 | 26.837 | 31.365 | 33.152 | 36.041 | 46.453 |
| Equity | 21.664 | 15.125 | 13.807 | 18.417 | 19.179 | 18.777 | 17.902 | 8.765 | 12.870 | 18.407 | 22.710 | 26.160 | 29.994 | 37.610 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 374 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8.539 | 1.778 | 2.947 | 1.768 | 3.003 | 4.564 | 3.534 | 8.726 | 8.358 | 8.420 | 8.647 | 6.989 | 6.040 | 8.838 |
| Total debt | 8.539 | 1.778 | 2.947 | 1.768 | 3.003 | 4.564 | 3.908 | 8.726 | 8.358 | 8.420 | 8.647 | 6.989 | 6.040 | 8.838 |
EBITDA margin
81.9%
This company
15.8%
Market median
+418% vs market
20122025
Equity ratio
81.0%
This company
38.2%
Market median
+112% vs market
20122025
Return on equity
20.2%
This company
18.4%
Market median
+10% vs market
20122025
Net profit margin
67.1%
This company
8.1%
Market median
+728% vs market
20122025
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20122025
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PA Founder | Founder | 1987 | — | — |
LR Management | Management | 2025 | — | — |
JJ Management | Management | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BJØRN THORSEN A/S | Company | 100.0% | 100.0% | 2019 |
KLARSØ HOLDING ApS | Company | 100.0% | 100.0% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ADSERBI A/S
Nordic Formulation Technology A/S Board members of Nordic Formulation Technology A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Adser | Founder | 0 companies |
| Lars Rønsholt | Management | 0 companies |
| Jacob Johansen | Management | 0 companies |
| Claus Adser | Chairman | 0 companies |
| Svend Christian Rimestad | Board of Directors | 0 companies |
| Dorthe Damm Asser Hansen | Board of Directors | 0 companies |
| Kasper Jalander | Board of Directors | 0 companies |